These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29677191)

  • 1. Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
    Pan G; Munukutla S; Kar A; Gardinier J; Thandavarayan RA; Palaniyandi SS
    PLoS One; 2018; 13(4):e0195796. PubMed ID: 29677191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF.
    Pan G; Roy B; Giri S; Lanfear DE; Thandavarayan RA; Guha A; Ortiz PA; Palaniyandi SS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine approach: Empagliflozin for diabetic cardiomyopathy in mice with aldehyde dehydrogenase (ALDH) 2 * 2 mutation, a specific genetic mutation in millions of East Asians.
    Pan G; Deshpande M; Pang H; Palaniyandi SS
    Eur J Pharmacol; 2018 Nov; 839():76-81. PubMed ID: 30240795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase 2 augments adiponectin signaling in coronary angiogenesis in HFpEF associated with diabetes.
    Roy B; Pan G; Giri S; Thandavarayan RA; Palaniyandi SS
    FASEB J; 2022 Aug; 36(8):e22440. PubMed ID: 35815932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.
    Wang C; Fan F; Cao Q; Shen C; Zhu H; Wang P; Zhao X; Sun X; Dong Z; Ma X; Liu X; Han S; Wu C; Zou Y; Hu K; Ge J; Sun A
    J Mol Med (Berl); 2016 Nov; 94(11):1229-1240. PubMed ID: 27488451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic-Reperfusion Injury Due to 4-Hydroxy-2-Nonenal Induced Coronary Endothelial Cell Damage.
    Pan G; Roy B; Palaniyandi SS
    J Am Heart Assoc; 2021 Sep; 10(18):e021140. PubMed ID: 34482710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases.
    Xia CL; Chu P; Liu YX; Qu XL; Gao XF; Wang ZM; Dong J; Chen SL; Zhang JX
    J Hum Hypertens; 2020 Jan; 34(1):16-23. PubMed ID: 30846829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function.
    Otto M; Brabenec L; Müller M; Kintrup S; Hellenthal KEM; Holtmeier R; Steinbuch SC; Karsten OS; Pryvalov H; Rossaint J; Gross ER; Wagner NM
    Life Sci; 2021 Nov; 284():119925. PubMed ID: 34480933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3β-mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy.
    Zhang Y; Zou R; Abudureyimu M; Liu Q; Ma J; Xu H; Yu W; Yang J; Jia J; Qian S; Wang H; Yang Y; Wang X; Fan X; Ren J
    J Mol Cell Biol; 2024 Apr; 15(9):. PubMed ID: 37771085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats.
    Wang J; Wang H; Hao P; Xue L; Wei S; Zhang Y; Chen Y
    Mol Med; 2011; 17(3-4):172-9. PubMed ID: 20957334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.
    Mali VR; Ning R; Chen J; Yang XP; Xu J; Palaniyandi SS
    Exp Biol Med (Maywood); 2014 May; 239(5):610-8. PubMed ID: 24651616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.
    Aboumsallem JP; Muthuramu I; Mishra M; De Geest B
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of the adrenergic reserve associated with exercise intolerance in a murine model of heart failure with preserved ejection fraction.
    Semmler L; Jeising T; Huettemeister J; Bathe-Peters M; Georgoula K; Roshanbin R; Sander P; Fu S; Bode D; Hohendanner F; Pieske B; Annibale P; Schiattarella GG; Oeing CU; Heinzel FR
    Acta Physiol (Oxf); 2024 Apr; 240(4):e14124. PubMed ID: 38436094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1α deacetylation.
    Wang S; Wang C; Turdi S; Richmond KL; Zhang Y; Ren J
    Int J Obes (Lond); 2018 Jun; 42(5):1073-1087. PubMed ID: 29535452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of exercise training in heart failure are lost in male diabetic rats.
    Boudia D; Domergue V; Mateo P; Fazal L; Prud'homme M; Prigent H; Delcayre C; Cohen-Solal A; Garnier A; Ventura-Clapier R; Samuel JL
    J Appl Physiol (1985); 2017 Dec; 123(6):1579-1591. PubMed ID: 28883044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
    Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
    J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function.
    Zhang Y; Babcock SA; Hu N; Maris JR; Wang H; Ren J
    BMC Med; 2012 Apr; 10():40. PubMed ID: 22524197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Cardiovascular Reserve to Prognostic Categories of Heart Failure With Preserved Ejection Fraction: A Classification Based on Machine Learning.
    Przewlocka-Kosmala M; Marwick TH; Dabrowski A; Kosmala W
    J Am Soc Echocardiogr; 2019 May; 32(5):604-615.e6. PubMed ID: 30718020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.